However, renal function, MMI, FN expression, SphK activity and S1P formation were significantly improved in diabetic SphK1-/- mice compared with diabetic WT mice, suggesting that intervention of SphK1 pathway may has beneficial effects in the treatment of DN. The gene discussed is FN1; the disease is liver dysplastic nodule.